Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Receivables (2016 - 2025)

Metlife (MET) has 17 years of Receivables data on record, last reported at $43.3 billion in Q3 2025.

  • For Q3 2025, Receivables rose 26.62% year-over-year to $43.3 billion; the TTM value through Sep 2025 reached $43.3 billion, up 26.62%, while the annual FY2024 figure was $3.0 billion, 90.41% down from the prior year.
  • Receivables reached $43.3 billion in Q3 2025 per MET's latest filing, up from $34.5 billion in the prior quarter.
  • Across five years, Receivables topped out at $43.3 billion in Q3 2025 and bottomed at $394.0 million in Q1 2022.
  • Average Receivables over 5 years is $17.4 billion, with a median of $19.8 billion recorded in 2022.
  • Peak YoY movement for Receivables: plummeted 97.92% in 2022, then soared 5626.13% in 2025.
  • A 5-year view of Receivables shows it stood at $19.8 billion in 2021, then grew by 0.19% to $19.8 billion in 2022, then skyrocketed by 59.28% to $31.6 billion in 2023, then plummeted by 90.41% to $3.0 billion in 2024, then skyrocketed by 1330.09% to $43.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $43.3 billion in Q3 2025, $34.5 billion in Q2 2025, and $31.6 billion in Q1 2025.